SUNNYVALE, Calif., Jan. 18, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Eric Pauwels has joined Accuray as Senior Vice President and Chief Marketing Officer, effective January 17, 2011.
Pauwels is a global industry leader with more than 25 years of general management experience in top-tier U.S. and European bio-pharmaceutical companies. He has successfully developed and launched more than 20 brands globally from major pharmaceuticals to highly specialized orphan drugs in the therapeutic areas of genetic diseases, cardiovascular disease, urology, gynecology, CNS/neuroscience and infectious disease. Pauwels brings more than 15 years of alliance management experience to his new role, having collaborated with commercial partners including GlaxoSmithKline, Genzyme, Dianippon-Sumitomo, Takeda, Abbott, Organon, and Centocor.
Pauwels played a key leadership role in building commercial capabilities in an early stage biotech company at Transkaryotic Therapies (TKT) and leading Shire's worldwide commercial business for its Human Genetic Disease biotech business unit where he served as SVP, Chief Commercial Officer. Prior to his tenure at Shire, Pauwels held senior management positions with Bayer Healthcare Pharmaceuticals as Vice President Global Strategic Marketing, Men's Health and Cardiovascular Diseases. Previous to this Pauwels held increasing responsibilities in technical operations, strategic marketing and general management functions leading businesses in the United States, China, France, and Belgium for Fournier Pharma and Johnson & Johnson.
"We are extremely excited to have Eric on board at Accuray. His deep global commercial and product launch experience will be an asset to our worldwide marketing efforts," sai